Calumet (CLMT) Cash & Equivalents (2022 - 2026)

Calumet (CLMT) has 5 years of Cash & Equivalents data on file, last reported at $138.6 million in Q1 2026.

• Cash & Equivalents for Q1 2026 came in at $138.6 million, up 12.32% year-over-year; the trailing twelve-month figure through Mar 2026 was $138.6 million (up 12.32% YoY), and the FY2025 annual result was $125.1 million, up 228.35% from the prior year.
• Cash & Equivalents rose to $138.6 million in Q1 2026 per CLMT's latest filing, from $125.1 million in the prior quarter.
• Over five years, Cash & Equivalents peaked at $138.6 million in Q1 2026 and troughed at $7.0 million in Q2 2024.
• A 5-year average of $61.2 million and a median of $38.1 million in 2024 frame the typical range for Cash & Equivalents.
• The sharpest annual moves came in 2024 and 2025: Cash & Equivalents sank 83.57% in 2024, then jumped 1480.0% in 2025.
• A 5-year view of Cash & Equivalents shows it stood at $35.2 million in 2022, then plunged by 77.56% to $7.9 million in 2023, then jumped by 382.28% to $38.1 million in 2024, then surged by 228.35% to $125.1 million in 2025, then climbed by 10.79% to $138.6 million in 2026.
• Business Quant data shows CLMT's Cash & Equivalents at $138.6 million in Q1 2026, $125.1 million in Q4 2025, and $94.6 million in Q3 2025.